Clinical Trials Directory

Trials / Completed

CompletedNCT05872087

Comparative Study Between Nebulised Dexmedetomidine and Nebulised Midazolam in Children Undergoing Lower Abdominal Surgeries

Comparative Study Between Nebulised Dexmedetomidine and Nebulised Midazolam in Reducing Preoperative Anxiety and Emergence Delirium in Children Undergoing Lower Abdominal Surgeries

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Ain Shams University · Academic / Other
Sex
All
Age
3 Years – 8 Years
Healthy volunteers
Accepted

Summary

Comparative study between nebulised dexmedetomidine and nebulized midazolam in reducing preoperative anxiety and emergence delirium in children undergoing lower abdominal surgeries

Detailed description

Dexmedetomidine is widely used in children and is replacing midazolam as the drug of choice for preoperative anxiolysis and sedation. However, there are limited studies comparing nebulized route in reducing preoperative anxiety and emergence delirium in children undergoing lower abdominal surgeries

Conditions

Interventions

TypeNameDescription
DRUGNebulised Dexmeditomidinepremedication by dexmeditomidine 3mcg/kg in children undergoing lower abdominal surgeries
DRUGNebulised Midazolampremedication by nebulised midazolam 0.3mg/kg in children undergoing lower abdominal surgeries

Timeline

Start date
2022-11-01
Primary completion
2023-09-01
Completion
2024-02-01
First posted
2023-05-24
Last updated
2024-05-24

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05872087. Inclusion in this directory is not an endorsement.

Comparative Study Between Nebulised Dexmedetomidine and Nebulised Midazolam in Children Undergoing Lower Abdominal Surge (NCT05872087) · Clinical Trials Directory